These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20695771)

  • 1. Hormonal contraception in women with the metabolic syndrome: a narrative review.
    Verhaeghe J
    Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):305-13. PubMed ID: 20695771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus.
    Wijeyaratne CN; Waduge R; Arandara D; Arasalingam A; Sivasuriam A; Dodampahala SH; Balen AH
    BJOG; 2006 Oct; 113(10):1182-7. PubMed ID: 16972862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
    Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
    J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M; Vick MR
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome.
    Kashanian M; Fazy Z; Pirak A
    Diabetes Res Clin Pract; 2008 May; 80(2):289-92. PubMed ID: 18294722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
    Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
    Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of developing metabolic syndrome after gestational diabetes mellitus.
    Akinci B; Celtik A; Yener S; Yesil S
    Fertil Steril; 2010 Mar; 93(4):1248-54. PubMed ID: 19147138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenicity of progestins in hormonal contraceptives and the risk of gestational diabetes mellitus.
    Hedderson MM; Ferrara A; Williams MA; Holt VL; Weiss NS
    Diabetes Care; 2007 May; 30(5):1062-8. PubMed ID: 17303784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraception in obesity, the metabolic syndrome, and diabetes.
    Skouby SO
    Ann N Y Acad Sci; 2010 Sep; 1205():240-4. PubMed ID: 20840279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome.
    Soares GM; Vieira CS; de Paula Martins W; Dos Reis RM; de Sá MF; Ferriani RA
    Int J Clin Pract; 2009 Jan; 63(1):160-9. PubMed ID: 18795969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F
    Ann N Y Acad Sci; 2006 Nov; 1083():54-62. PubMed ID: 17148733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.